ISPC

iSpecimen Inc. ISPC

ISPC
iSpecimen Inc. SERA
Sera Prognostics, Inc. PRPO
Precipio, Inc. BIAF
bioAffinity Technologies, Inc. MDXH
MDxHealth S.A. BFRI
Biofrontera Inc. LGVN
Longeveron Inc. PTPI
Petros Pharmaceuticals, Inc. KTTA
Pasithea Therapeutics Corp. SOPA
Society Pass Incorporated

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ISPC SERA PRPO BIAF MDXH BFRI LGVN PTPI KTTA SOPA
6M -34.91 % -8.08 % 231.86 % -82.27 % 169.23 % 17.60 % -44.82 % -98.03 % -36.93 % 283.04 %
YTD -70.16 % -63.15 % 249.81 % -90.57 % 82.61 % -13.58 % -55.30 % -99.81 % -74.60 % 196.62 %
1Y -80.64 % -57.12 % 191.60 % -95.26 % 107.92 % 15.02 % -58.76 % -99.70 % -84.27 % 183.33 %
3Y -97.24 % 93.08 % 11.47 % -96.62 % -37.69 % -96.11 % -97.69 % -99.98 % -97.02 % -87.75 %
5Y -99.42 % -74.20 % -57.77 % -98.93 % -65.00 % -98.93 % -98.92 % -100.00 % -98.95 % -99.62 %
10Y -99.42 % -74.20 % -99.31 % -98.93 % -65.00 % -98.93 % -98.92 % -100.00 % -98.95 % -99.62 %
From the beginning -99.42 % -74.20 % -99.31 % -98.93 % -65.00 % -98.93 % -98.92 % -100.00 % -98.95 % -99.62 %

Dividend